United States Antimony Corporation Reports Third Quarter and Nine Months Ended September 30, 2025 Financial and Operating Results
Rhea-AI Summary
United States Antimony Corporation (NYSE:UAMY) reported third-quarter and nine-month results for the period ended September 30, 2025. Revenues for the first nine months rose to $26.23M, a 182% increase year-over-year; gross profit rose 219% to $7.22M and gross margin improved to 28%. The company recorded a $4.05M net loss YTD including $5.18M of non-cash expenses. Cash and securities totaled $38.5M at Sept 30, 2025 after $16.07M capex YTD. Inventory held 230 tons of antimony (~$9.2M at Rotterdam prices). Company narrowed 2025 revenue guidance to $40–$43M and reiterated 2026 guidance of $125M. Announced two five-year supply contracts totaling up to $352M.
Positive
- Revenues +182% year-to-date to $26.23M
- Gross profit +219% year-to-date to $7.22M
- Cash and federal securities balance of $38.5M at Sept 30, 2025
- Secured two five-year contracts totaling up to $352M
- Recorded 230 tons antimony inventory (~$9.2M value)
Negative
- Net loss of $4.05M for nine months ended Sept 30, 2025
- Operating expenses rose to $11.76M YTD, up $8.19M
- Non-cash share-based compensation expense of $4.69M YTD
- Capital expenditures of $16.07M YTD reduced cash flexibility
News Market Reaction
On the day this news was published, UAMY declined 5.58%, reflecting a notable negative market reaction. Argus tracked a peak move of +7.5% during that session. Argus tracked a trough of -11.6% from its starting point during tracking. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $66M from the company's valuation, bringing the market cap to $1.13B at that time.
Data tracked by StockTitan Argus on the day of publication.
Revenues Up
Gross Profit Up
“The Critical Minerals and ZEO Company”
~ Antimony, Cobalt, Tungsten, and Zeolite ~
DALLAS, TEXAS / ACCESS Newswire / November 12, 2025 / United States Antimony Corporation ("USAC," "US Antimony Corporation," or the "Company"), (NYSE American:UAMY)(NYSE Texas:UAMY) reported today its third quarter and nine months ended September 30, 2025 financial and operational results.
Revenues for the first nine months of 2025 increased to
The Company incurred a net loss of
Our antimony sales were
Our zeolite sales were
The Company's cash position, including its investment in securities (federal bonds), totaled
USAC's current antimony inventory year-to-date has all been acquired from international third-party suppliers and currently sits at record levels. As of September 30, 2025, inventory totaled 230 tons of antimony (both processed and unprocessed). The value of this inventory at today's Rotterdam market price is approximately
Today the Company is narrowing its revenue financial guidance for fiscal year 2025 and reiterating its 2026 revenue financial guidance:
2025 Revenues -
2026 Revenues -
Commenting on the Third Quarter and Nine Months Ended September 30, 2025 financial and operational results, Mr. Gary C. Evans, Chairman and CEO of US Antimony Corporation stated, "The third quarter marked a continued improvement in our overall financial performance. We successfully secured two major sales contracts over the last 60 days - a five-year, sole-source IDIQ contract with the U.S. Defense Logistics Agency valued at up to
Conference Call Details
US Antimony management will host a conference call on Wednesday, November 12, 2025, at 4:15 p.m. Eastern time to discuss its full financial results for the Third Quarter and Nine Months Ended September 30, 2025, followed by a question-and-answer period. The conference call details are as follows:
Date: Wednesday, November 12, 2025
Time: 4:15 p.m. Eastern time
Toll-free dial-in Number: 888-506-0062
International dial-in number: 973-528-0011
Participant Access Code: 876721
Webcast URL: https://www.webcaster5.com/Webcast/Page/2604/53183
The conference call will also be available for replay in the Investors section of the Company's website, along with the transcript, at https://www.usantimony.com/investors.
About USAC:
United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," "U.S. Antimony," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S., Mexico, and Canada. The Company mines, purchases, and processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The Company also recovers precious metals, primarily gold and silver, at its Montana facility from third party ore. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. Beginning in 2024, the Company began acquiring mining claims, real properties (patented claims) and leases located in Alaska, Montana and Ontario, Canada in an effort to reduce the cost of third-party antimony ore purchases.
Learn more about United States Antimony Corporation at www.usantimony.com.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company's future operations, production levels, financial performance, business strategy, market conditions, demand for antimony, zeolite, other critical minerals, and precious metals, expected costs, and other statements that are not historical facts. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as management's beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," "could," and variations of these words or similar expressions are intended to identify such forward-looking statements.
Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in such statements, including, but not limited to: fluctuations in the market prices and demand for antimony and zeolite; changes in domestic and global economic conditions; operational risks inherent in mining and mineral processing; geological or metallurgical conditions; availability and cost of energy, equipment, transportation, and labor; the Company's ability to maintain or obtain permits, licenses, and regulatory approvals; changes in environmental and mining laws or regulations; competitive factors; the impact of geopolitical developments; and the effects of weather, natural disasters, or health pandemics on operations and supply chains. Additional information regarding risk factors that could cause actual results to differ materially is included in the Company's filings with the U.S. Securities and Exchange Commission, including the most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.
The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Investor Relations Contact: Media Relations Contact:
Jonathan Miller, VP, Investor Relations | Anthony D. Andora | |
4438 W. Lovers Lane, Unit 100 | Edge Consulting, Inc. | |
Dallas, Texas 75209 | 1560 Market Street, Ste. 701 | |
E-Mail: Jmiller@usantimony.com | Denver, Colorado 80202 | |
Phone: 406-606-4117 | ||
Phone: 720-317-8927 |
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Revenues | $ | 8,701,951 | $ | 2,572,178 | $ | 26,227,079 | $ | 9,307,222 | ||||||||
Cost of revenues | 6,688,509 | 2,148,349 | 19,004,362 | 7,043,685 | ||||||||||||
Gross profit | 2,013,442 | 423,829 | 7,222,717 | 2,263,537 | ||||||||||||
Operating expenses: | ||||||||||||||||
General and administrative | 882,909 | 610,888 | 2,276,455 | 1,614,048 | ||||||||||||
Salaries and benefits | 4,940,319 | 429,438 | 7,305,380 | 956,402 | ||||||||||||
Professional fees | 522,531 | 184,402 | 1,441,436 | 637,418 | ||||||||||||
(Gain) loss on sale or disposal of property, plant and equipment | (8,216 | ) | (16,252 | ) | (8,716 | ) | 1,242 | |||||||||
Gain on lease termination | (469,822 | ) | - | (469,822 | ) | - | ||||||||||
Other operating expenses | 1,062,903 | 106,374 | 1,217,167 | 359,894 | ||||||||||||
Total operating expenses | 6,930,624 | 1,314,850 | 11,761,900 | 3,569,004 | ||||||||||||
Loss from operations | (4,917,182 | ) | (891,021 | ) | (4,539,183 | ) | (1,305,467 | ) | ||||||||
Other income (expense), net: | ||||||||||||||||
Interest and investment income | 150,563 | 157,757 | 472,719 | 460,529 | ||||||||||||
Trademark and licensing income | 7,867 | 6,553 | 25,337 | 21,281 | ||||||||||||
Other miscellaneous expense | (21,948 | ) | (798 | ) | (11,494 | ) | (23,828 | ) | ||||||||
Total other income, net | 136,482 | 163,512 | 486,562 | 457,982 | ||||||||||||
Loss before income taxes | (4,780,700 | ) | (727,509 | ) | (4,052,621 | ) | (847,485 | ) | ||||||||
Income tax expense | - | - | - | - | ||||||||||||
Net loss | (4,780,700 | ) | (727,509 | ) | (4,052,621 | ) | (847,485 | ) | ||||||||
Preferred dividends | (1,875 | ) | (1,875 | ) | (5,625 | ) | (5,625 | ) | ||||||||
Net loss available to common shareholders | $ | (4,782,575 | ) | $ | (729,384 | ) | $ | (4,058,246 | ) | $ | (853,110 | ) | ||||
Net loss per share: | ||||||||||||||||
Basic | $ | (0.04 | ) | $ | (0.01 | ) | $ | (0.03 | ) | $ | (0.01 | ) | ||||
Diluted | $ | (0.04 | ) | $ | (0.01 | ) | $ | (0.03 | ) | $ | (0.01 | ) | ||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 123,412,910 | 108,438,984 | 118,494,796 | 108,262,091 | ||||||||||||
Diluted | 123,412,910 | 108,438,984 | 118,494,796 | 108,262,091 | ||||||||||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
September 30, | December 31, | |||||||
2025 | 2024 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash and cash equivalents | $ | 18,338,679 | $ | 18,172,120 | ||||
Investment securities held to maturity | 1,270,666 | - | ||||||
Accounts receivable, net | 1,898,184 | 1,099,771 | ||||||
Inventories | 8,413,161 | 1,245,724 | ||||||
Prepaid expenses and other current assets | 1,877,249 | 160,954 | ||||||
Total current assets | 31,797,939 | 20,678,569 | ||||||
Property, plant and equipment, net | 28,121,338 | 12,891,447 | ||||||
Operating lease right-of-use assets | 36,288 | 565,289 | ||||||
Investment securities held to maturity - noncurrent | 18,886,727 | - | ||||||
Restricted cash for reclamation bonds | 131,402 | 98,778 | ||||||
IVA receivable and other assets, net | 908,647 | 408,519 | ||||||
Total assets | $ | 79,882,341 | $ | 34,642,602 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
CURRENT LIABILITIES | ||||||||
Accounts payable | $ | 4,218,043 | $ | 1,545,708 | ||||
Accrued liabilities | 1,581,627 | 1,427,146 | ||||||
Accrued liabilities - directors | 89,530 | 141,287 | ||||||
Royalties payable | 207,445 | 133,434 | ||||||
Current portion of operating lease liabilities | 28,990 | 626,562 | ||||||
Current portion of long-term debt | 135,754 | 132,252 | ||||||
Total current liabilities | 6,261,389 | 4,006,389 | ||||||
Operating lease liabilities, net of current portion | 7,298 | 129,007 | ||||||
Long-term debt, net of current portion | 93,167 | 195,425 | ||||||
Asset retirement obligations | 1,769,557 | 1,711,108 | ||||||
Total liabilities | 8,131,411 | 6,041,929 | ||||||
COMMITMENTS AND CONTINGENCIES | ||||||||
STOCKHOLDERS' EQUITY | ||||||||
Preferred stock | ||||||||
Series A - no shares issued and outstanding | - | - | ||||||
Series B - 750,000 shares issued and outstanding (liquidation preference | 7,500 | 7,500 | ||||||
Series C - 177,904 shares issued and outstanding (liquidation preference | 1,779 | 1,779 | ||||||
Series D - no shares issued and outstanding | - | - | ||||||
Common stock, | 1,303,382 | 1,129,512 | ||||||
Treasury stock (140,860 and no shares of common stock at cost, respectively) | (510,675 | ) | - | |||||
Additional paid-in capital | 116,150,588 | 68,610,905 | ||||||
Accumulated deficit | (45,201,644 | ) | (41,149,023 | ) | ||||
Total stockholders' equity | 71,750,930 | 28,600,673 | ||||||
Total liabilities and stockholders' equity | $ | 79,882,341 | $ | 34,642,602 | ||||
UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Nine months ended September 30, | ||||||||
2025 | 2024 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net loss | $ | (4,052,621 | ) | $ | (847,485 | ) | ||
Adjustments to reconcile loss to net cash (used in) provided by operating activities: | ||||||||
Depreciation and amortization | 839,353 | 340,217 | ||||||
Accretion of asset retirement obligation | 58,449 | 54,813 | ||||||
Noncash operating lease expense | 289,542 | 18,611 | ||||||
Share-based compensation | 4,688,772 | 453,566 | ||||||
Accretion income from investment securities held to maturity | (222,440 | ) | - | |||||
(Gain) loss on sale or disposal of property, plant and equipment, net | (8,716 | ) | 1,242 | |||||
Gain on lease termination | (469,822 | ) | - | |||||
Write-down of inventory to net realizable value | - | 63,574 | ||||||
Change in allowance for credit losses | 5,798 | (30,746 | ) | |||||
Other noncash items | - | (16,107 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (804,211 | ) | (175,748 | ) | ||||
Inventories | (7,167,437 | ) | 324,264 | |||||
Prepaid expenses and other current assets | (1,726,295 | ) | (87,824 | ) | ||||
IVA receivable and other assets, net | (500,128 | ) | 60,856 | |||||
Accounts payable | 2,672,335 | 889,242 | ||||||
Accrued liabilities | 154,481 | 46,129 | ||||||
Accrued liabilities - directors | (51,757 | ) | 34,355 | |||||
Royalties payable | 74,011 | (48,255 | ) | |||||
Stock payable to directors | - | (38,542 | ) | |||||
Net cash (used in) provided by operating activities | (6,220,686 | ) | 1,042,162 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Proceeds from redemption of certificates of deposit | - | 50,641 | ||||||
Purchases of investment securities held to maturity | (19,934,953 | ) | - | |||||
Proceeds from sales of property, plant and equipment | 8,716 | 314,125 | ||||||
Purchases of property, plant and equipment | (16,069,244 | ) | (223,058 | ) | ||||
Net cash (used in) provided by investing activities | (35,995,481 | ) | 141,708 | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Principal payments on long-term debt | (98,756 | ) | (71,139 | ) | ||||
Proceeds from exercises of stock options | 55,000 | - | ||||||
Treasury stock acquired | (409,246 | ) | - | |||||
Proceeds from issuance of common stock, net of issuance costs | 38,440,596 | - | ||||||
Proceeds from exercise of warrants | 4,427,756 | - | ||||||
Net cash provided by (used in) financing activities | 42,415,350 | (71,139 | ) | |||||
NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | 199,183 | 1,112,731 | ||||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 18,270,898 | 11,954,635 | ||||||
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $ | 18,470,081 | $ | 13,067,366 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Interest paid in cash | $ | 14,642 | $ | 5,630 | ||||
NON-CASH FINANCING AND INVESTING ACTIVITIES: | ||||||||
Recognition of operating lease liability and right-of-use asset | $ | 63,416 | $ | 787,477 | ||||
Equipment purchased with note payable | $ | - | $ | 402,722 | ||||
SOURCE: United States Antimony Corp.
View the original press release on ACCESS Newswire